During the past decade, Raleigh Neurology Associates conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 32 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 20 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Raleigh Neurology Associates" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Jazz Pharmaceuticals" with 5 trials sponsored, "Acorda Therapeutics" with 4 trials sponsored, "Allergan" with 4 trials sponsored and "Biogen" with 4 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Raleigh Neurology Associates" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Raleigh Neurology Associates" are "Multiple Sclerosis" (19 trials), "Alzheimer's Disease" (15 trials), "Alzheimer Disease" (9 trials), "Narcolepsy" (4 trials) and "Parkinson's Disease" (4 trials). Many other conditions were trialed in "Raleigh Neurology Associates" in a lesser frequency.

Most popular intervention types in "Raleigh Neurology Associates" are "Drug" (78 trials), "Other" (6 trials), "Biological" (4 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Ocrelizumab" (6 trials), "placebo" (5 trials), "Bapineuzumab 0.5 mg/kg" (3 trials) and "Fampridine-SR" (3 trials). Other intervention names were less common.

The vast majority of trials in "Raleigh Neurology Associates" are 88 trials for "All" genders.

Currently, there are NaN active trials in "Raleigh Neurology Associates". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 59 completed trials in Raleigh Neurology Associates, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Raleigh Neurology Associates, 1 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".